Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuesetong capsule is a Chinese Patent Medicine (CPM) containing total saponins extracted from *Panax notoginseng* (PNS). It is widely utilized in clinical practice in China for the treatment of cardiovascular and cerebrovascular diseases, particularly ischemic stroke and coronary heart disease. The therapeutic effects are attributed to its ability to inhibit platelet aggregation, reduce blood viscosity, improve microcirculation, and provide neuroprotection by mitigating oxidative stress and inflammatory responses. In the context of stroke recovery, it is used to improve neurological function and activities of daily living during the convalescence phase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xuesetong capsule.